Introduction: Individualized homeopathy (IH) in atopic dermatitis (AD) remained under-researched. Objective: We aimed at evaluating efficacy of IH in AD. Methods: A double-blind, randomized, placebo-controlled, short-term, preliminary trial was conducted in an Indian homeopathy hospital. Patients were randomized to either IH (n = 30) or identical-looking placebo (n = 30) using computerized randomization and allocation. Outcomes were patient-oriented scoring of AD (PO-SCORAD; primary end point), Dermatological Life Quality Index (DLQI) score, and AD burden score for adults (ADBSA; secondary end points), measured monthly for 3 months. An intention-to-treat sample was analyzed after adjusting baseline differences. Results: On PO-SCORAD, improvement was higher in IH against placebo, but nonsignificant statistically (pmonth 1 = 0.433, pmonth 2 = 0.442, pmonth 3 = 0.229). Secondary outcomes were also nonsignificant – both DLQI and ADBSA (p > 0.05). Four adverse events (diarrhea, injury, common cold) were recorded. Conclusions: There was a small, but nonsignificant direction of effect towards homeopathy, which renders the trial inconclusive. A properly powered robust trial is indicated.

1.
Saeki
H
,
Nakahara
T
,
Tanaka
A
,
Kabashima
K
,
Sugaya
M
,
Murota
H
, et al;
Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Association
.
Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
.
J Dermatol
.
2016
Oct
;
43
(
10
):
1117
45
.
[PubMed]
0385-2407
2.
Chow
S
,
Seow
CS
,
Dizon
MV
,
Godse
K
,
Foong
H
,
Chan
V
, et al;
Asian Academy of Dermatology & Venereology
.
A clinician’s reference guide for the management of atopic dermatitis in Asians
.
Asia Pac Allergy
.
2018
Oct
;
8
(
4
):
e41
.
[PubMed]
2233-8276
3.
Rajagopalan
M
,
De
A
,
Godse
K
,
Krupa Shankar
DS
,
Zawar
V
,
Sharma
N
, et al
Guidelines on Management of Atopic Dermatitis in India: An Evidence-Based Review and an Expert Consensus
.
Indian J Dermatol
.
2019
May-Jun
;
64
(
3
):
166
81
.
[PubMed]
0019-5154
4.
Sidbury
R
,
Kodama
S
.
Atopic dermatitis guidelines: Diagnosis, systemic therapy, and adjunctive care
.
Clin Dermatol
.
2018
Sep - Oct
;
36
(
5
):
648
52
.
[PubMed]
0738-081X
5.
Bantz
SK
,
Zhu
Z
,
Zheng
T
.
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
.
J Clin Cell Immunol
.
2014
Apr
;
5
(
2
):
202
.
[PubMed]
2155-9899
6.
Pols
DH
,
Wartna
JB
,
Moed
H
,
van Alphen
EI
,
Bohnen
AM
,
Bindels
PJ
.
Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: a systematic review
.
Scand J Prim Health Care
.
2016
Jun
;
34
(
2
):
143
50
.
[PubMed]
0281-3432
7.
Black
D
. Complementary Medicine. In:
Walter
J
,
Walton
L
,
Jeremiah
A
,
Barondess
JA
,
Lock
S
, editors
.
The Oxford Medical Companion
.
Oxford
:
Oxford University Press
;
1994
.
8.
Loudon
I
.
A brief history of homeopathy
.
J R Soc Med
.
2006
Dec
;
99
(
12
):
607
10
.
[PubMed]
0141-0768
9.
Cukaci
C
,
Freissmuth
M
,
Mann
C
,
Marti
J
,
Sperl
V
.
Against all odds-the persistent popularity of homeopathy
.
Wien Klin Wochenschr
.
2020
May
;
132
(
9-10
):
232
42
.
[PubMed]
0043-5325
10.
Prasad
R
.
Homoeopathy booming in India
.
Lancet
.
2007
Nov
;
370
(
9600
):
1679
80
.
[PubMed]
0140-6736
11.
WHO global report on traditional and complementary medicine 2019. Geneva: World Health Organization;
2019
. License: CC BYNC-SA 3.0 IGO. Available from: https://apps.who.int/iris/bitstream/handle/10665/312342/9789241515436-eng.pdf?ua=1 [Accessed 29 Aug 2020].
12.
Relton
C
,
Cooper
K
,
Viksveen
P
,
Fibert
P
,
Thomas
K
.
Prevalence of homeopathy use by the general population worldwide: a systematic review
.
Homeopathy
.
2017
May
;
106
(
2
):
69
78
.
[PubMed]
1475-4916
13.
Ghosh
AK
.
A short history of the development of homeopathy in India
.
Homeopathy
.
2010
Apr
;
99
(
2
):
130
6
.
[PubMed]
1475-4916
14.
Ernst
E
.
Homeopathy for eczema: a systematic review of controlled clinical trials
.
Br J Dermatol
.
2012
Jun
;
166
(
6
):
1170
2
.
[PubMed]
0007-0963
15.
Witt
CM
,
Lüdtke
R
,
Baur
R
,
Willich
SN
.
Homeopathic medical practice: long-term results of a cohort study with 3981 patients
.
BMC Public Health
.
2005
Nov
;
5
(
1
):
115
.
[PubMed]
1471-2458
16.
Siebenwirth
J
,
Lüdtke
R
,
Remy
W
,
Rakoski
J
,
Borelli
S
,
Ring
J
.
[Effectiveness of a classical homeopathic treatment in atopic eczema. A randomised placebo-controlled double-blind clinical trial]
.
Forsch Komplement Med
.
2009
Oct
;
16
(
5
):
315
23
.
[PubMed]
1661-4119
17.
Keil
T
,
Witt
CM
,
Roll
S
,
Vance
W
,
Weber
K
,
Wegscheider
K
, et al
Homoeopathic versus conventional treatment of children with eczema: a comparative cohort study
.
Complement Ther Med
.
2008
Feb
;
16
(
1
):
15
21
.
[PubMed]
0965-2299
18.
Koley
M
,
Saha
S
,
Arya
JS
,
Choubey
G
,
Ghosh
S
,
Purkait
R
, et al
A study on drug utilization and prescription habits of physicians in a government homeopathic hospital in West Bengal, India
.
J Integr Med
.
2013
Sep
;
11
(
5
):
305
13
.
[PubMed]
2095-4964
19.
Fisher
P
,
McCarney
R
,
Hasford
C
,
Vickers
A
.
Evaluation of specific and non-specific effects in homeopathy: feasibility study for a randomised trial
.
Homeopathy
.
2006
Oct
;
95
(
4
):
215
22
.
[PubMed]
1475-4916
20.
Witt
CM
,
Brinkhaus
B
,
Pach
D
,
Reinhold
T
,
Wruck
K
,
Roll
S
, et al
Homoeopathic versus conventional therapy for atopic eczema in children: medical and economic results
.
Dermatology
.
2009
;
219
(
4
):
329
40
.
[PubMed]
1018-8665
21.
Adler
U
,
Adler
M
.
Homeopathic Q-potencies for atopic dermatitis
.
Eur J Integr Med
.
2010
;
2
(
4
):
175
6
. 1876-3820
22.
Witt
CM
,
Lüdtke
R
,
Willich
SN
.
Homeopathic treatment of children with atopic eczema: a prospective observational study with two years follow-up
.
Acta Derm Venereol
.
2009
;
89
(
2
):
182
3
.
[PubMed]
0001-5555
23.
Eizayaga
JE
,
Eizayaga
JI
.
Prospective observational study of 42 patients with atopic dermatitis treated with homeopathic medicines
.
Homeopathy
.
2012
Jan
;
101
(
1
):
21
7
.
[PubMed]
1475-4916
24.
Itamura
R
,
Hosoya
R
.
Homeopathic treatment of Japanese patients with intractable atopic dermatitis
.
Homeopathy
.
2003
Apr
;
92
(
2
):
108
14
.
[PubMed]
1475-4916
25.
Rossi
E
,
Bartoli
P
,
Bianchi
A
,
Da Frè
M
.
Homeopathy in paediatric atopic diseases: long-term results in children with atopic dermatitis
.
Homeopathy
.
2012
Jan
;
101
(
1
):
13
20
.
[PubMed]
1475-4916
26.
Williams
HC
,
Burney
PG
,
Hay
RJ
,
Archer
CB
,
Shipley
MJ
,
Hunter
JJ
, et al
The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis
.
Br J Dermatol
.
1994
Sep
;
131
(
3
):
383
96
.
[PubMed]
0007-0963
27.
Kunz
B
,
Oranje
AP
,
Labrèze
L
,
Stalder
JF
,
Ring
J
,
Taïeb
A
.
Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis
.
Dermatology
.
1997
;
195
(
1
):
10
9
.
[PubMed]
1018-8665
28.
Barrett
A
,
Hahn-Pedersen
J
,
Kragh
N
,
Evans
E
,
Gnanasakthy
A
.
Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults
.
Patient
.
2019
Oct
;
12
(
5
):
445
59
.
[PubMed]
1178-1653
29.
Rehal
B
,
Armstrong
AW
.
Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010
.
PLoS One
.
2011
Apr
;
6
(
4
):
e17520
.
[PubMed]
1932-6203
30.
Finlay
AY
,
Khan
GK
.
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use
.
Clin Exp Dermatol
.
1994
May
;
19
(
3
):
210
6
.
[PubMed]
0307-6938
31.
Badia
X
,
Mascaró
JM
,
Lozano
R
;
The Cavide Research Group
.
Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI
.
Br J Dermatol
.
1999
Oct
;
141
(
4
):
698
702
.
[PubMed]
0007-0963
32.
Lewis
V
,
Finlay
AY
.
10 years experience of the Dermatology Life Quality Index (DLQI)
.
J Investig Dermatol Symp Proc
.
2004
Mar
;
9
(
2
):
169
80
.
[PubMed]
1087-0024
34.
Taïeb
A
,
Boralevi
F
,
Seneschal
J
,
Merhand
S
,
Georgescu
V
,
Taieb
C
, et al
Atopic dermatitis burden scale for adults: development and validation of a new assessment tool
.
Acta Derm Venereol
.
2015
Jul
;
95
(
6
):
700
5
.
[PubMed]
0001-5555
35.
Stub
T
,
Salamonsen
A
,
Alraek
T
.
Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study
.
Forsch Komplement Med
.
2012
;
19
(
1
):
13
9
.
[PubMed]
1661-4119
36.
Stub
T
,
Alraek
T
,
Salamonsen
A
.
The Red flag! risk assessment among medical homeopaths in Norway: a qualitative study
.
BMC Complement Altern Med
.
2012
Sep
;
12
(
1
):
150
.
[PubMed]
1472-6882
37.
Stub
T
,
Kristoffersen
AE
,
Alræk
T
,
Musial
F
,
Steinsbekk
A
.
Risk in homeopathy: classification of adverse events and homeopathic aggravations—A cross sectional study among Norwegian homeopath patients
.
Complement Ther Med
.
2015
Aug
;
23
(
4
):
535
43
.
[PubMed]
0965-2299
38.
Schulz
KF
,
Altman
DG
,
Moher
D
;
CONSORT Group
.
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
.
BMJ
.
2010
Mar
;
340
mar23 1
:
c332
.
[PubMed]
0959-8138
39.
Dean
ME
,
Coulter
MK
,
Fisher
P
,
Jobst
K
,
Walach
H
.
Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT
.
Homeopathy
.
2007
Jan
;
96
(
1
):
42
5
.
[PubMed]
1475-4916
40.
Lilienthal
S
.
Homoeopathic Therapeutics: The Classical Therapeutic Hints
. 21st ed.
New Delhi
:
B. Jain Publishers Pvt. Ltd.
;
2013
. pp.
370
.
41.
Hoyne
TS
. Clinical Therapeutics. 2nd ed. Chicago: Culver, Page, Hoyne & Co., Printers;
1880
, pp. 168, 360, 580.
42.
Kent
JT
(
Jain
K
, editor
).
New Remedies, Clinical Cases, Lesser Writings, Aphorisms and Percepts
.
New Delhi
:
B. Jain Publishers Pvt. Ltd.
;
2004
. p.
170
.
43.
Kent
JT
(
Jain
K
, editor
).
Lectures on Homeopathic Materia Medica
.
New Delhi
:
B. Jain Publishers Pvt. Ltd.
;
2005
. p.
167
.
44.
Nash
EB
(
Jain
K
, editor
).
Leaders in Homeopathic Therapeutics with Grouping and Classification
.
New Delhi
:
B. Jain Publishers Pvt. Ltd.
;
2002
. pp.
535
.
45.
Hahnemann
CF
. The Chronic Diseases: their Peculiar Nature and their Homoeopathic Cure (Vol. 1). New Delhi: B. Jain Publishers Pvt. Ltd.; 1981, pp. 11, 14. Douglass ME. Skin diseases, their description, etiology, diagnosis and treatment according to the law of similars. New Delhi: Indian Books & Periodicals Syndicate;
2006
, p. 41. Burnett J. Diseases of the skin: their constitutional nature and cure (1st preface). London: The Homoeopathic Publishing Company; 1893, p. viii.
46.
Douglass ME. Skin diseases, their description, etiology, diagnosis and treatment according to the law of similars. New Delhi: Indian Books & Periodicals Syndicate; 2006. p. 41.
47.
Burnett J. Diseases of the skin: their constitutional nature and cure (1st preface). London: The Homoeopathic Publishing Company; 1893. p. viii.
48.
Roberts
HA
. Principles and art of cure by homoeopathy. Ch. VIII. Taking the case. Reprint ed., Indian Books and Periodicals Publishers, New Delhi,
May
2006
, p. 78.
49.
Hahnemann
CF
.
Organon of Medicine
. 5th ed.
New Delhi
:
B. Jain Publishers Pvt. Ltd.
;
2002
. p.
98
.
50.
Hackshaw
A
.
Small studies: strengths and limitations
.
Eur Respir J
.
2008
Nov
;
32
(
5
):
1141
3
.
[PubMed]
0903-1936
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.